Cargando...
Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management
Molecularly targeted cancer therapy has rapidly changed the landscape of oncologic care, often improving patients’ prognosis without causing as substantial a quality-of-life decrement as cytotoxic chemotherapy does. Nevertheless, targeted agents can cause side effects that may be less familiar to me...
Guardado en:
| Publicado en: | Oncologist |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AlphaMed Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5189614/ https://ncbi.nlm.nih.gov/pubmed/27473045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0519 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|